Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD)

CUSIP: 002942100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share (the "Shares")
Shares outstanding
21,303,054
Total 13F shares
10,747,406
Share change
+850,529
Total reported value
$141,005,712
Price per share
$13.12
Number of holders
65
Value change
+$11,023,600
Number of buys
48
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 002942100?
CUSIP 002942100 identifies AARD - Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD) as of Q4 2025

As of 31 Dec 2025, Aardvark Therapeutics, Inc. - Common Stock, par value $0.00001 per share (the "Shares") (AARD) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,747,406 shares. The largest 10 holders included Decheng Capital LLC, CITADEL ADVISORS LLC, Laurion Capital Management LP, BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, SymBiosis Capital Partners, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 65 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.